Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-02-03

FDA Approved: LABETALOL HYDROCHLORIDE — Supplemental Application (NorthStar Rx LLC)

View source ↗

Summary

FDA approved a supplemental application for labetalol hydrochloride submitted by NorthStar Rx LLC under an ANDA. The approval confirms the regulatory status of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Labetalol Hydrochloride (Labetalol hydrochloride)

Snippet

SUPPL AP for LABETALOL HYDROCHLORIDE (LABETALOL HYDROCHLORIDE)